Key Findings:  The aim of this review was to identify potential biomarkers for Interstitial cystitis/bladder pain syndrome (IC/BPS) for which targets within the endocannabinoid system are showing promising targets in the development of therapeutic agents.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Israel
Year of Pub:  2021
Cannabinoids Studied:  Endocannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable